Yazhuo Wang

Shijiazhuang, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Global, regional, and national burden of ovarian cancer in women aged 45 + from 1990 to 2021 and projections for 2050: a systematic analysis based on the 2021 global burden of disease study.

Global, regional, and national burden of ovarian cancer in women aged 45 + from 1990 to 2021 and projections for 2050: a systematic analysis based on the 2021 global burden of disease study.

Journal: Journal of cancer research and clinical oncology

Published: June 11, 2025

Impact of TRMT6 on prognosis and immune microenvironment in ovarian cancer.

Impact of TRMT6 on prognosis and immune microenvironment in ovarian cancer.

Journal: Frontiers in oncology

Published: May 27, 2025

Establishment and verification of a nomogram model based on the inflammatory indicators of patients with cervical cancer for predicting the risk of their lymph node metastasis.

Establishment and verification of a nomogram model based on the inflammatory indicators of patients with cervical cancer for predicting the risk of their lymph node metastasis.

Journal: PeerJ

Published: May 07, 2025

A circular economy approach for the global lithium-ion battery supply chain.

A circular economy approach for the global lithium-ion battery supply chain.

Journal: Nature

Published: February 09, 2025

Development and Validation of a Nomogram for Prognostic Prediction in Ovarian Cancer Based on Tumor Proliferation and Immune-Related Biomarkers in Chinese Patients.

Development and Validation of a Nomogram for Prognostic Prediction in Ovarian Cancer Based on Tumor Proliferation and Immune-Related Biomarkers in Chinese Patients.

Journal: International journal of women's health

Published: January 17, 2025

NFIC suppressed the epithelial ovarian cancer via modulating the balance of PTEN/TGFβ1/EGR1/BRD4 and SP1/EZH2 induced Inhibition of TBX2/MMPs signaling.

NFIC suppressed the epithelial ovarian cancer via modulating the balance of PTEN/TGFβ1/EGR1/BRD4 and SP1/EZH2 induced Inhibition of TBX2/MMPs signaling.

Journal: Scientific reports

Published: November 26, 2024

Association between the C-reactive protein-triglyceride-glucose index and endometriosis: a cross-sectional study using data from the national health and nutrition examination survey, 1996-2006.

Association between the C-reactive protein-triglyceride-glucose index and endometriosis: a cross-sectional study using data from the national health and nutrition examination survey, 1996-2006.

Journal: BMC women's health

Published: September 30, 2024

Effects of MFG-E8 expression on the biological characteristics of ovarian cancer cells via the AKT/mTOR/S6K signalling pathway.

Effects of MFG-E8 expression on the biological characteristics of ovarian cancer cells via the AKT/mTOR/S6K signalling pathway.

Journal: Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology

Published: December 09, 2022

Identification of N1 methyladenosine-related biomarker predicting overall survival outcomes and experimental verification in ovarian cancer.

Identification of N1 methyladenosine-related biomarker predicting overall survival outcomes and experimental verification in ovarian cancer.

Journal: The journal of obstetrics and gynaecology research

Published: December 05, 2022

Rab11a promotes the malignant progression of ovarian cancer by inducing autophagy.

Rab11a promotes the malignant progression of ovarian cancer by inducing autophagy.

Journal: Genes & genomics

Published: May 16, 2022

Association of BRCA1/2 mutations with prognosis and surgical cytoreduction outcomes in ovarian cancer patients: An updated meta-analysis.

Association of BRCA1/2 mutations with prognosis and surgical cytoreduction outcomes in ovarian cancer patients: An updated meta-analysis.

Journal: The journal of obstetrics and gynaecology research

Published: February 11, 2022

MiR-193a-5p serves as an inhibitor in ovarian cancer cells through RAB11A.

MiR-193a-5p serves as an inhibitor in ovarian cancer cells through RAB11A.

Journal: Reproductive toxicology (Elmsford, N.Y.)

Published: December 13, 2021

Showing 1-12 of 12

Last Updated: 09/26/2026